IJGC conversations

Surgery for Stage IV Ovarian Cancer with Floriane Jochum

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Floriane Jochum to discuss Surgery for Stage IV Ovarian Cancer.
Dr. Floriane Jochum is a Gynecologic Oncologist at Strasbourg University Hospital in France. She recently completed her PhD in cancer research and computational epidemiology at Institut Curie in Paris. Her doctoral work focused on the multiple applications of real-world data in gynecologic oncology, exploring topics ranging from disparities in access to care to the development of emulated clinical trials. 

Rare gynecologic cancers with IJGC fellows

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by the IJGC editorial fellows to discuss the IJGC Special Issue on Rare gynecologic cancers. 

QoL Assessment on SHAPE Trial with Sarah E. Ferguson

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Sarah E. Ferguson to discuss QoL Assessment on SHAPE Trial.
Dr. Sarah Ferguson is a Gynecologic Oncologist at Princess Margaret Cancer Centre (University Health Network), a Professor and Vice Chair of Research in the Department of Obstetrics and Gynecology at the University of Toronto, and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital. Dr. Ferguson is currently the Head of Research for the Department of Obstetrics and Gynecology for Mount Sinai Hospital/University Health Network. Her clinical and research interests include: improving surgical techniques and patient outcomes, survivorship and supportive care as well as hereditary cancer syndromes in gynecology, in particular Lynch syndrome.

De-escalation in Gynecologic Oncology with Núria Agustí

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Núria Agustí to discuss De-escalation in Gynecologic Oncology. Dr. Agustí specializes in gynecologic oncology at Hospital Clinic of Barcelona. She is currently a PhD researcher at the University of Barcelona and engaged in a postdoctoral fellowship at MD Anderson Cancer Center, USA. She recently completed the IJGC Editorial Fellowship program

IJGC conversations 2025 February Editor's Choice

In this episode of the IJGC conversations 2025 February Editor's Choice, Editorial Fellow Matteo Marchetti and Thomas Bartl discusses the contents of the 2025 February issue of IJGC. 

LANCE Trial: Results of Feasibility Phase with Jose Alejandro Rauh-Hain

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jose Alejandro Rauh-Hain to discuss LANCE Trial: Results of Feasibility Phase.
Dr. Rauh-Hain is a Gynecologic Oncologist at the University of Texas MD Anderson Cancer Center. Born in Mexico City, he earned his medical degree from Universidad Panamericana and completed a research fellowship at Massachusetts General Hospital, focusing on preeclampsia biomarkers. He trained in Obstetrics and Gynecology at Massachusetts General and Brigham and Women's Hospital, followed by a Gynecologic Oncology fellowship at Harvard Medical School. He also holds an MPH from Harvard and completed a post-doctoral fellowship in Cancer Outcomes Research. His interests include gynecologic cancer surgery, rare tumor management, and research on reducing disparities in cancer care.

Ovarian cancer risk among older patients with stable adnexal masses with Elizabeth (Betty) Suh-Burgmann

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Elizabeth (Betty) Suh-Burgmann to discuss Ovarian cancer risk among older patients with stable adnexal masses.
Dr. Elizabeth (Betty) Suh-Burgmann, originally from Boulder, Colorado, earned her Bachelor of Arts from Cornell University and completed her medical degree and residency at the University of California, San Francisco. Following a fellowship at Massachusetts General Hospital/Harvard Medical School, she joined Kaiser Permanente in 2000. She is the Chair of Gynecologic Oncology for Kaiser Permanente Northern California, which provides care to approximately 4.4 million patients. She is the recipient of the 2022 Sidney Garfield Exceptional Contribution Award for her work establishing a standardized ultrasound ovarian cancer risk assessment system within Kaiser. Her research interests include cancer and precancer of the uterus, borderline tumors of the ovary, ultrasound detection of ovarian cancer and cervical cancer screening. 

Preoperative Tumor Size and Final Pathology in Cervical Cancer with Teresa Pan

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Teresa Pan to discuss Preoperative Tumor Size and Final Pathology in Cervical Cancer. Dr. Teresa Pan is a gynonc doctor in the Innsbruck Medical University, Department of Gynecology and Obstetrics and has an interest in research in cervical cancer.

Oral Contraceptive Impact on p53 Signatures with Ramlogan Sowamber

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Ramlogan Sowamber to discuss Oral Contraceptive Impact on p53 Signatures. Ramlogan Sowamber is a trainee at the University of British Columbia in the department of Medical Genetics, working with Dr. David Huntsman on understanding the impacts of opportunistic salpingectomy on ovarian cancer risk reduction from a genomic and molecular perspective. He is interested in understanding how genetics influences the mechanisms of cancer progression using genomic and functional approaches and how therapeutic interventions can be applied to various cancer subtypes.

PRIMA Trial: Overall Survival Results with Antonio González-Martín

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Antonio González-Martín to discuss the results of overall survival in the PRIMA trial. Dr. Antonio González-Martín specializes in the treatment of gynaecological and breast cancer and is the chairman of GEICO (Spanish group for investigation in ovarian and gynaecological cancer). He is also the representative of GEICO in ENGOT (European Network for Gynaecological Oncological Trials), and was the President of this Group for the period 2018-2020. In addition, he is one of the representatives of GEICO in Gynaecologic Cancer InterGroup (GCIG), and has served as chair of the ovarian cancer committee for the period 2014-2020. He is also a member of the board of the Spanish Society of Medical Oncology (SEOM), and a member of GEICAM and SOLTI breast cancer cooperative groups.